3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
6
Pancreatic Neoplasms
5
Colorectal Neoplasms
4
Rectal Neoplasms
3
Colonic Neoplasms
3
Agnosia
3
Liver Neoplasms
2
Stomach Neoplasms
1
Pain
1
Neuralgia
1
Neoplasms
1
Intestinal Perforation
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Ileus
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Duodenal Neoplasms
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Diverticulitis
1
Digestive System Diseases
1
Crohn Disease
1
Constipation
1
Interventions
Oxaliplatin
29
Fluorouracil
25
Leucovorin
20
Capecitabine
18
Irinotecan
17
Surveys and Questionnaires
16
Bevacizumab
14
Cisplatin
12
Blood Specimen Collection
11
Drug Therapy
10
Standard of Care
9
Nivolumab
9
Gemcitabine
9
Cetuximab
7
pembrolizumab
6
Specimen Handling
6
S 1 (combination)
6
Endoscopic Mucosal Resection
6
Cyclophosphamide
6
atezolizumab
5
Sunitinib
5
Radiotherapy
5
Folfox protocol
5
Educational Status
5
Docetaxel
5
fludarabine
4
aldesleukin
4
Radiosurgery
4
Pemetrexed
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Bupivacaine
×
Gastrointestinal
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts